J. Dutcher

Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma

Jeffrey A. Sosman, Carole Carrillo, Walter J. Urba et al. · Journal of Clinical Oncology · 2008 · 104 citations · Full text

ECOG 8802: Phase II trial of doxorubicin (Dox) and gemcitabine (Gem) in metastatic renal cell carcinoma (RCC) with sarcomatoid features

N. B. Haas, Judith Manola, Michael Pins et al. · Journal of Clinical Oncology · 2009 · 18 citations

Ecog 8802, Immunology, Pharmacotherapy +19

Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-α to patients with advanced renal cell carcinoma

J. W. Smith, Yoo-Joung Ko, J. Dutcher et al. · Journal of Clinical Oncology · 2004 · 17 citations

Renal Pathology, Renal Inflammation, Pharmacotherapy +16

A GPIbα-Related Protein Is Expressed by Fresh Human Breast Carcinoma Tissue and Is Regulated by a PKC-Sensitive Mechanism☆

Leslie Oleksowicz, J. Dutcher, Polly R. Etkind · Experimental Cell Research · 1997 · 13 citations

Tumor Biology, Gpibα-related Protein, Breast Oncology +10

7113 Radiographic findings of drug-induced pneumonitis and clinical correlation in patients with advanced renal cell carcinoma treated with temsirolimus

Maria Santolaya-De Pablo, G. R. Hudes, J. Dutcher et al. · European Journal of Cancer Supplements · 2009 · 11 citations

Urology, Clinical Correlation, Radiographic Findings +6